Literature DB >> 27068306

Clinical Perspectives and Pearls from the 2015 ESC NSTE-ACS Guidelines.

Marco Roffi1, Baris Gencer2, Robert F Storey3, Felicita Andreotti4, Carlo Patrono5.   

Abstract

Four years after the latest edition, the 2015 non-ST-segment elevation acute coronary syndromes guidelines of the European Society of Cardiology have been published. Novel aspects include a new diagnostic algorithm for non-ST-segment elevation myocardial infarction using high-sensitivity cardiac troponins as well as guidance on cardiac rhythm monitoring duration. A large section is dedicated to antiplatelet therapy including initiation and duration of dual-antiplatelet therapy as well as the management of patients requiring, at the same time, long-term oral anticoagulation. New sections include the management of antiplatelet agent in patients requiring coronary artery bypass surgery and of acute bleeding events related to antiplatelet agents, vitamin K antagonist (VKA), and non-VKA oral anticoagulant drugs. Current evidence supports the radial access over the femoral one for coronary angiography and percutaneous revascularization.

Entities:  

Keywords:  Antiplatelet agents; Guidelines; High-sensitivity cardiac troponins; Myocardial infarction; P2Y12 inhibitors; Radial approach

Mesh:

Substances:

Year:  2016        PMID: 27068306     DOI: 10.1007/s11886-016-0722-0

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  10 in total

1.  Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes.

Authors:  Gilles Montalescot; Leonardo Bolognese; Dariusz Dudek; Patrick Goldstein; Christian Hamm; Jean-Francois Tanguay; Jurrien M ten Berg; Debra L Miller; Timothy M Costigan; Jochen Goedicke; Johanne Silvain; Paolo Angioli; Jacek Legutko; Margit Niethammer; Zuzana Motovska; Joseph A Jakubowski; Guillaume Cayla; Luigi Oltrona Visconti; Eric Vicaut; Petr Widimsky
Journal:  N Engl J Med       Date:  2013-09-01       Impact factor: 91.245

2.  Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates.

Authors:  Marco Valgimigli; Athanasios Patialiakas; Attila Thury; Eugene McFadden; Salvatore Colangelo; Gianluca Campo; Matteo Tebaldi; Imre Ungi; Stefano Tondi; Marco Roffi; Alberto Menozzi; Nicoletta de Cesare; Roberto Garbo; Emanuele Meliga; Luca Testa; Henrique Mesquita Gabriel; Flavio Airoldi; Marco Ferlini; Francesco Liistro; Antonio Dellavalle; Pascal Vranckx; Carlo Briguori
Journal:  J Am Coll Cardiol       Date:  2015-03-03       Impact factor: 24.094

3.  ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).

Authors:  Christian W Hamm; Jean-Pierre Bassand; Stefan Agewall; Jeroen Bax; Eric Boersma; Hector Bueno; Pio Caso; Dariusz Dudek; Stephan Gielen; Kurt Huber; Magnus Ohman; Mark C Petrie; Frank Sonntag; Miguel Sousa Uva; Robert F Storey; William Wijns; Doron Zahger
Journal:  Eur Heart J       Date:  2011-08-26       Impact factor: 29.983

4.  Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Authors:  Christopher P Cannon; Michael A Blazing; Robert P Giugliano; Amy McCagg; Jennifer A White; Pierre Theroux; Harald Darius; Basil S Lewis; Ton Oude Ophuis; J Wouter Jukema; Gaetano M De Ferrari; Witold Ruzyllo; Paul De Lucca; KyungAh Im; Erin A Bohula; Craig Reist; Stephen D Wiviott; Andrew M Tershakovec; Thomas A Musliner; Eugene Braunwald; Robert M Califf
Journal:  N Engl J Med       Date:  2015-06-03       Impact factor: 91.245

5.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White; Kristian Thygesen; Joseph S Alpert; Harvey D White; Allan S Jaffe; Hugo A Katus; Fred S Apple; Bertil Lindahl; David A Morrow; Bernard A Chaitman; Peter M Clemmensen; Per Johanson; Hanoch Hod; Richard Underwood; Jeroen J Bax; Robert O Bonow; Fausto Pinto; Raymond J Gibbons; Keith A Fox; Dan Atar; L Kristin Newby; Marcello Galvani; Christian W Hamm; Barry F Uretsky; Ph Gabriel Steg; William Wijns; Jean-Pierre Bassand; Phillippe Menasché; Jan Ravkilde; E Magnus Ohman; Elliott M Antman; Lars C Wallentin; Paul W Armstrong; Maarten L Simoons; James L Januzzi; Markku S Nieminen; Mihai Gheorghiade; Gerasimos Filippatos; Russell V Luepker; Stephen P Fortmann; Wayne D Rosamond; Dan Levy; David Wood; Sidney C Smith; Dayi Hu; José-Luis Lopez-Sendon; Rose Marie Robertson; Douglas Weaver; Michael Tendera; Alfred A Bove; Alexander N Parkhomenko; Elena J Vasilieva; Shanti Mendis
Journal:  Eur Heart J       Date:  2012-08-24       Impact factor: 29.983

6.  Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS).

Authors:  Gregory Y H Lip; Stephan Windecker; Kurt Huber; Paulus Kirchhof; Francisco Marin; Jurriën M Ten Berg; Karl Georg Haeusler; Giuseppe Boriani; Davide Capodanno; Martine Gilard; Uwe Zeymer; Deirdre Lane; Robert F Storey; Hector Bueno; Jean-Philippe Collet; Laurent Fauchier; Sigrun Halvorsen; Maddalena Lettino; Joao Morais; Christian Mueller; Tatjana S Potpara; Lars Hvilsted Rasmussen; Andrea Rubboli; Juan Tamargo; Marco Valgimigli; Jose L Zamorano
Journal:  Eur Heart J       Date:  2014-08-25       Impact factor: 29.983

7.  Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk.

Authors:  Philip Urban; Ian T Meredith; Alexandre Abizaid; Stuart J Pocock; Didier Carrié; Christoph Naber; Janusz Lipiecki; Gert Richardt; Andres Iñiguez; Philippe Brunel; Mariano Valdes-Chavarri; Philippe Garot; Suneel Talwar; Jacques Berland; Mohamed Abdellaoui; Franz Eberli; Keith Oldroyd; Robaayah Zambahari; John Gregson; Samantha Greene; Hans-Peter Stoll; Marie-Claude Morice
Journal:  N Engl J Med       Date:  2015-10-14       Impact factor: 91.245

Review 8.  Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials.

Authors:  Jacob A Udell; Marc P Bonaca; Jean-Philippe Collet; A Michael Lincoff; Dean J Kereiakes; Francesco Costa; Cheol Whan Lee; Laura Mauri; Marco Valgimigli; Seung-Jung Park; Gilles Montalescot; Marc S Sabatine; Eugene Braunwald; Deepak L Bhatt
Journal:  Eur Heart J       Date:  2015-08-31       Impact factor: 29.983

9.  Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials.

Authors:  Eliano Pio Navarese; Felicita Andreotti; Volker Schulze; Michalina Kołodziejczak; Antonino Buffon; Marc Brouwer; Francesco Costa; Mariusz Kowalewski; Gianfranco Parati; Gregory Y H Lip; Malte Kelm; Marco Valgimigli
Journal:  BMJ       Date:  2015-04-16

10.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

Authors:  Marco Roffi; Carlo Patrono; Jean-Philippe Collet; Christian Mueller; Marco Valgimigli; Felicita Andreotti; Jeroen J Bax; Michael A Borger; Carlos Brotons; Derek P Chew; Baris Gencer; Gerd Hasenfuss; Keld Kjeldsen; Patrizio Lancellotti; Ulf Landmesser; Julinda Mehilli; Debabrata Mukherjee; Robert F Storey; Stephan Windecker
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

  10 in total
  2 in total

1.  Using Thromboelastography to Predict Blood Loss After Off-Pump Coronary Artery Bypass Grafting.

Authors:  Yu Liu; Wen-Li Zhang; Ji-Qiang Bu; Jian-Jun Gu; Yong-Quan Sun; Hong-Zhan Cui; Da-Wei Wang; Zi-Ying Chen
Journal:  Int J Gen Med       Date:  2021-03-19

2.  Effect of thrombelastography on timing of coronary artery bypass grafting.

Authors:  Zhiyuan Yang; Zhouliang Xie; Xueliang Pei; Xiaoqiang Quan; Deguang Feng
Journal:  Exp Ther Med       Date:  2018-05-21       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.